Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NFκB activation

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 6, 2014, Pages 606-613

  Aguilar, E C ^a   Leonel, A J ^a   Teixeira, L G ^a   Silva, A R ^a   Silva, J F ^a   Pelaez, J M N ^a   Capettini, L S A ^a   Lemos, V S ^a   Santos, R A S ^a   Alvarez Leite, J I ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Atherosclerosis; Butyrate; Fatty acid; Macrophage

Indexed keywords

BUTYRIC ACID; CD36 ANTIGEN; COLLAGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1; ANTIOXIDANT; NONSTEROID ANTIINFLAMMATORY AGENT; TRANSCRIPTION FACTOR RELA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA VALVE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHEMOTAXIS; COLLAGEN DEGRADATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE TEST; INFLAMMATION; LIPID TRANSPORT; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; AORTA; CELL ADHESION; CELL CULTURE; CELL LINE; CELL MOTION; CELL NUCLEUS; DIET THERAPY; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PERITONEUM MACROPHAGE; PLAQUE, ATHEROSCLEROTIC; PROTEIN TRANSPORT; VASCULAR ENDOTHELIUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD36; ANTIOXIDANTS; AORTA; AORTIC VALVE; ATHEROSCLEROSIS; BUTYRIC ACID; CELL ADHESION; CELL LINE; CELL MOVEMENT; CELL NUCLEUS; CELLS, CULTURED; DIETARY SUPPLEMENTS; ENDOTHELIUM, VASCULAR; HUMANS; MACROPHAGES, PERITONEAL; MALE; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; PROTEIN TRANSPORT; TRANSCRIPTION FACTOR RELA;

EID: 84901490188     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.01.002     Document Type: Article

References (30)

1. Yang H, Mohamed AS, Zhou SH. Oxidized low density lipoprotein, stem cells, and atherosclerosis. Lipids Health Dis 11:85.
2. Yamamoto Y., Gaynor R.B. Role of the nf-kappab pathway in the pathogenesis of human disease states. Curr Mol Med 2001, 1:287-296.
3. Vieira E.L., Leonel A.J., Sad A.P., Beltrao N.R., Costa T.F., Ferreira T.M., et al. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. J Nutr Biochem 2012, 23:430-436.
4. Leonel A.J., Alvarez-Leite J.I. Butyrate: implications for intestinal function. Curr Opin Clin Nutr Metab Care 2012, 15:474-479.
5. Ferreira T.M., Leonel A.J., Melo M.A., Santos R.R., Cara D.C., Cardoso V.N., et al. Oral supplementation of butyrate reduces mucositis and intestinal permeability associated with 5-fluorouracil administration. Lipids 2012, 47:669-678.
6. Monneret C. Histone deacetylase inhibitors. Eur J Med Chem 2005, 40:1-13.
7. Bailon E., Cueto-Sola M., Utrilla P., Rodriguez-Cabezas M.E., Garrido-Mesa N., Zarzuelo A., et al. Butyrate invitro immune-modulatory effects might be mediated through a proliferation-related induction of apoptosis. Immunobiology 2010, 215:863-873.
8. Zapolska-Downar D., Siennicka A., Kaczmarczyk M., Kolodziej B., Naruszewicz M. Butyrate inhibits cytokine-induced vcam-1 and icam-1 expression in cultured endothelial cells: the role of nf-kappab and pparalpha. J Nutr Biochem 2004, 15:220-228.
9. Segain J.P., Raingeard de la Bletiere D., Bourreille A., Leray V., Gervois N., Rosales C., et al. Butyrate inhibits inflammatory responses through nfkappab inhibition: implications for crohn's disease. Gut 2000, 47:397-403.
10. Leonel A.J., Teixeira L.G., Oliveira R.P., Santiago A.F., Batista N.V., Ferreira T.R., et al. Antioxidative and immunomodulatory effects of tributyrin supplementation on experimental colitis. Br J Nutr 2012, 109:1396-1407.
11. Palinski W., Ord V.A., Plump A.S., Breslow J.L., Steinberg D., Witztum J.L. Apoe-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb 1994, 14:605-616.
12. Aguilar E.C., Jascolka T.L., Teixeira L.G., Lages P.C., Ribeiro A.C., Vieira E.L., et al. Paradoxical effect of a pequi oil-rich diet on the development of atherosclerosis: balance between antioxidant and hyperlipidemic properties. Braz J Med Biol Res 2012, 45:601-609.
13. Teixeira L.G. White tea (camellia sinensis) extract reduces oxidative stress and triacylglycerols in obese mice. Food Sci Technol 2012, 32:733-741.
14. Capettini L.S., Cortes S.F., Silva J.F., Alvarez-Leite J.I., Lemos V.S. Decreased production of neuronal nos-derived hydrogen peroxide contributes to endothelial dysfunction in atherosclerosis. Br J Pharmacol 2011, 164:1738-1748.
15. Brasier AR. The nuclear factor-kappab-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res 86:211-8.
16. Alvaro A., Sola R., Rosales R., Ribalta J., Anguera A., Masana L., et al. Gene expression analysis of a human enterocyte cell line reveals downregulation of cholesterol biosynthesis in response to short-chain fatty acids. IUBMB Life 2008, 60:757-764.
17. Demigne C., Morand C., Levrat M.A., Besson C., Moundras C., Remesy C. Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes. Br J Nutr 1995, 74:209-219.
18. VanderLaan P.A., Reardon C.A., Getz G.S. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol 2004, 24:12-22.
19. Ramos M.G., Rabelo F.L., Duarte T., Gazzinelli R.T., Alvarez-Leite J.I. Butyrate induces apoptosis in murine macrophages via caspase-3, but independent of autocrine synthesis of tumor necrosis factor and nitric oxide. Braz J Med Biol Res 2002, 35:161-173.
20. Rubic T., Lorenz R.L. Downregulated cd36 and oxldl uptake and stimulated abca1/g1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10. Cardiovasc Res 2006, 69:527-535.
21. Page-McCaw A., Ewald A.J., Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007, 8:221-233.
22. Sasaki T, Nakamura K, Sasada K, Okada S, Cheng XW, Suzuki T, etal. Matrix metalloproteinase-2 deficiency impairs aortic atherosclerotic calcification in apoe-deficient mice. Atherosclerosis 227:43-50.
23. Miyoshi M., Sakaki H., Usami M., Iizuka N., Shuno K., Aoyama M., et al. Oral administration of tributyrin increases concentration of butyrate in the portal vein and prevents lipopolysaccharide-induced liver injury in rats. Clin Nutr 2011, 30:252-258.
24. Niu Q.X., Chen H.Q., Chen Z.Y., Fu Y.L., Lin J.L., He S.H. Induction of inflammatory cytokine release from human umbilical vein endothelial cells by agonists of proteinase-activated receptor-2. Clin Exp Pharmacol Physiol 2008, 35:89-96.
25. Gomaraschi M., Basilico N., Sisto F., Taramelli D., Eligini S., Colli S., et al. High-density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro-inflammatory stimuli. Biochim Biophys Acta 2005, 1736:136-143.
26. Murray P.J. The primary mechanism of the il-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc Natl Acad Sci U S A 2005, 102:8686-8691.
27. Han C.Y., Park S.Y., Pak Y.K. Role of endocytosis in the transactivation of nuclear factor-kappab by oxidized low-density lipoprotein. Biochem J 2000, 350(Pt 3):829-837.
28. Oeckinghaus A., Ghosh S. The nf-kappab family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 2009, 1:a000034.
29. Machado R.A., Constantino Lde S., Tomasi C.D., Rojas H.A., Vuolo F.S., Vitto M.F., et al. Sodium butyrate decreases the activation of nf-kappab reducing inflammation and oxidative damage in the kidney of rats subjected to contrast-induced nephropathy. Nephrol Dial Transplant 2012, 27:3136-3140.
30. Schwab M., Reynders V., Loitsch S., Steinhilber D., Stein J., Schroder O. Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible nf kappa b signalling. Mol Immunol 2007, 44:3625-3632.